News

This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.

Genentech will leverage Medra's Physical AI, Scientific AI and robotics into its lab systems to accelerate drug discovery.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

Screening rates in northern Queensland lag behind the statewide average.

The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.

The report shows that enterprise AI adoption has surged, with healthcare among the fastest‑growing sectors at 8x year‑over‑year adoption.

CLEAR's biometric ID verification will be added to Welldoc's cardiometabolic care app, a move the companies say supports federal efforts to build a more connected health ecosystem.

The goal is to make artificial intelligence available to the federal workforce and to integrate it across internal operations, research and public health.

Investors are funneling capital into early-stage automation and clinical support tools that use AI to counter workforce shortages, according to the report.

According to healthcare leaders, 2025 was a pivotal year for AI and digital health, marked by technological progress, a shifting focus on its role in healthcare and practical use cases driving its adoption.